Big news in the world of medicine! Johnson & Johnson (J&J), a huge company that makes medicines, is suing Samsung Bioepis. It's all about a special medicine called Stelara, which helps people with psoriasis. Samsung made a cheaper copy, but J&J says Samsung broke their agreement.
- J&J says Samsung didn't follow the rules when it launched its cheaper Stelara copy.
- J&J wants to stop Samsung from selling its copy in the US.
- Stelara is a super popular and expensive medicine, making J&J a lot of money.
- This is like a big fight over who gets to sell a popular medicine.
| Fact | Detail |
|---|---|
| Stelara Sales (2024) | Over $10 billion |
| Number of Stelara copies expected in US this year | At least seven |
| Similar situation with Humira | Abbvie (Humira's maker) also faced biosimilar competition. |
